Drug
Insulin icodec clinical trials
Also written Insulin 287.
Keep track of what changes. Save the insulin icodec studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
33 studies that test it; most in 2021 (7); 1 more planned to start later
| Year | Studies |
|---|---|
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 4 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 33 · Other 1
Novo Nordisk A/S (33) · Xi'an International Medical Center Hospital (1)
Often tested with
Tested in the same studies.
Semaglutide (7) · Insulin Glargine (3) · Insulin degludec (1) · NNC0148 (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypoglycemic Agents source
Studies
Open first, then newest update. How each study uses insulin icodec is read from its arms, and is right about nine times in ten.
Testing it · 34
- A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 DiabetesRecruitingPhase 4Novo Nordisk A/SNCT07112339Written as Insulin icodec
- Insulin Icodec Initiation Strategies and Day-4 Supplemental Dosing in Type 2 DiabetesNot yet recruitingPhase 4Xi'an International Medical Center HospitalNCT07747402Written as Insulin icodec
- A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesActive, not recruitingPhase 3Novo Nordisk A/SNCT07076199Written as Insulin icodec
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedPhase 3Novo Nordisk A/SNCT04760626Written as Insulin icodec
- A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT06340854Written as Insulin icodec
- A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)CompletedPhase 3Novo Nordisk A/SNCT04795531Written as Insulin icodec
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)CompletedPhase 3Novo Nordisk A/SNCT05259033Written as IcoSema
- A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged FastingCompletedPhase 1Novo Nordisk A/SNCT06288412Written as Insulin icodec
- A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)CompletedPhase 3Novo Nordisk A/SNCT06269107Written as IcoSema
- A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 DiabetesCompletedPhase 3Novo Nordisk A/SNCT05813912Written as Insulin Icodec
- A Study Using Flash Glucose Measurements for a New Once-weekly Insulin (Insulin Icodec) in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 9)CompletedPhase 3Novo Nordisk A/SNCT05823948Written as Insulin Icodec
- A Study to Test How New Long-acting Insulin (Insulin Icodec) Works in the Body of Children and TeenagersCompletedPhase 1Novo Nordisk A/SNCT05790681Written as Insulin icodec
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily InsulinCompletedPhase 3Novo Nordisk A/SNCT04770532Written as Insulin Icodec
- A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)CompletedPhase 3Novo Nordisk A/SNCT04848480Written as insulin icodec
- A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Glargine, Both in Combination With Mealtime Insulin, in People With Type 2 Diabetes Who Use Daily Insulin and Mealtime Insulin (ONWARDS 4)CompletedPhase 3Novo Nordisk A/SNCT04880850Written as Insulin icodec
- A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin BeforeCompletedPhase 3Novo Nordisk A/SNCT04460885Written as Insulin icodec
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Insulin IcodecCompletedPhase 3Novo Nordisk A/SNCT05352815Written as IcoSema
- A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)CompletedPhase 3Novo Nordisk A/SNCT05013229Written as IcoSema
- A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or TogetherCompletedPhase 1Novo Nordisk A/SNCT05435677Written as IcoSema
- A Research Study of How Different Doses of a New Medicine NNC0148-0287 C (Insulin 287) Work on the Blood Sugar in People With Type 1 Diabetes When it is Taken Once a WeekCompletedPhase 1Novo Nordisk A/SNCT03723772Written as Insulin icodec
See all 34 studies that test insulin icodec →
Given in every arm · 1 — insulin icodec is usual care beside what is tested
As the comparator · 2 — what is tested is compared with insulin icodec
- A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult MalesRecruitingPhase 1The United Bio-Technology (Hengqin) Co., Ltd.NCT07630233Written as Insulin Icodec Injection
- A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal InsulinRecruitingPhase 3Gan & Lee Pharmaceuticals.NCT07165223Written as Insulin Icodec group
Codes
What other systems call insulin icodec · ClinicalTrials.gg INT001500
- MeSH (NLM) C000712207insulin icodecConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) P7YU3ED05NINSULIN ICODECConfirmed FDA, NLM, Wikidata
- Wikidata Q111982305insulin icodecConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C175800Insulin IcodecOne source FDA
- DrugBank DB16693One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000712207 | insulin icodec | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | P7YU3ED05N | INSULIN ICODEC | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q111982305 | insulin icodec | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C175800 | Insulin Icodec | One source FDA |
| DrugBank | DB16693 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.